»ó´Ü¿©¹é
±â»ç (Àüü 737°Ç)
[Sub Story] FENO, ÀÓ»óÀû À¯¿ë¼º¿¡ ¹«°Ô ½Ç¸°´Ù ÀÓ¼¼Çü ±âÀÚ 2017-05-29 16:17
[Sub Story] COPD ¾ÇÈ­ ¿Ü·¡È¯ÀÚ, ´Ü±â°£ ¡®°æ±¸¿ë¡¯ ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å Ä¡·á ÀÓ¼¼Çü ±âÀÚ 2017-05-29 16:15
[Interview] ¡°Áø´Ü±âÁØ¿¡¼­ FEV1 ¹èÁ¦ ¿©ÆÄ¡¦±¹³» ±Ù°Å °ËÅä Áß¡± ÀÓ¼¼Çü ±âÀÚ 2017-05-29 16:11
[Interview] ¡°±¹³» õ½ÄȯÀÚ °ü¸® Å°¿öµå, ³ëÀΰú ±³À°¡± ÀÓ¼¼Çü ±âÀÚ 2017-05-29 16:07
[Sub Story] GINA Guideline ÁÖ±âÀû õ½ÄÆò°¡ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2017-05-29 15:25
¶óÀÎ
[Sub Story] Ç×ü¾à¹° Ãß°¡·Î ¡®Á¤¹ÐÄ¡·á¡¯ º¸¿Ï ÀÓ¼¼Çü ±âÀÚ 2017-05-29 14:52
[Drug Review] ¡®³Ø½ºÆ®ÇÒ·¯¡¯·Î õ½Ä Ä¡·áÈ¿°ú ²ø¾î¿Ã¸°´Ù ÀÓ¼¼Çü ±âÀÚ 2017-05-29 14:46
[Drug Review] ÇÁ¶õ·çÄ«½ºÆ® ´ÙÁßÁ¦¾î±â¼ú LTRA ÀÓ¼¼Çü ±âÀÚ 2017-05-26 18:09
[Sub Story] ACOS¿¡¼­ ACO·Î¡¦Æä³ëŸÀÔ ¿ªÇÒ¿¡ ¹«°Ô ÀÓ¼¼Çü ±âÀÚ 2017-05-26 17:59
[Sub Story] ACOS ±¹³» ±âÁØ¡¤±Ù°Å ÇÊ¿ä ÀÓ¼¼Çü ±âÀÚ 2017-05-26 17:50
¶óÀÎ
[Sub Story] ÀÓ»óÇöÀå ÇÙ½ÉÁú¹®¿¡ ´äÇÏ´Ù ÀÓ¼¼Çü ±âÀÚ 2017-05-26 17:47
[Sub Story] 2¼¼´ë Ç×È÷½ºÅ¸¹ÎÁ¦ °­·Â ±Ç°í ÀÓ¼¼Çü ±âÀÚ 2017-05-26 17:45
[Drug Review] µ¦»ç¸ÞŸ¼Õ ½ÃÆä½Ç·¹ÀÌÆ® Åë³â¼º ºñ¿°Ä¡·á Àå±â°£ È¿°ú¡¤¾ÈÀü¼º È®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2017-05-26 17:18
[Cover Story] È£Èí±âÁúȯ °ü¸®¡®Á¤¹ÐÀÇÇС¯ ¿µ¿ªÀ¸·Î ÀÓ¼¼Çü ±âÀÚ 2017-05-26 17:13
[Late Breaking Studies] °áÇÙ, »õ·Î¿î Ä¡·áÀü·«À¸·Î ÅðÄ¡ °¡¼ÓÈ­ ÀÓ¼¼Çü ±âÀÚ 2017-05-26 17:06
¶óÀÎ
[Late Breaking Studies] ºÎµ¥¼Ò´Ïµå/Æ÷¸£¸ðÅ×·Ñ Ãµ½Ä ¡®3´Ü°è¡¯ °ü¸®Àü·« ÀçÈ®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2017-05-26 16:57
[Expert Opinion] »õ·Î¿î ÀÎÇ÷翣ÀÚ Ä¡·áÁ¦ PeramivirÀÇ È°¿ë ¹æ¾È ÀÓ¼¼Çü ±âÀÚ 2017-05-26 16:46
[Deep in Guideline] Æó¾Ï¡¤¹ÚÅ׸®¾Æ°¨¿° ±âħ °ü¸®Àü·« ÀÓ¼¼Çü ±âÀÚ 2017-05-26 15:50
[Sub Story] ¾Æ³ª±Û¸³Æ¾, Á׻󵿸ưæÈ­Áõ ÇýÅà ½Ã»ç ÀÓ¼¼Çü ±âÀÚ 2017-05-01 10:02
[Sub Story] Àν¶¸° µ¥±Û·çµ¦ Ç÷´ç º¯µ¿¼º °³¼± È®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2017-05-01 09:39
Back to Top